{"count":2,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/1f83cd21-b004-44fa-b4fb-14775e4033d5/","filing_uuid":"1f83cd21-b004-44fa-b4fb-14775e4033d5","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1f83cd21-b004-44fa-b4fb-14775e4033d5/print/","filing_document_content_type":"text/html","income":null,"expenses":"640000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Elizabeth Sharp","dt_posted":"2026-07-20T16:31:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"222 Jacobs Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Cambridge","registrant_state":"MA","registrant_zip":"02141","registrant":{"id":31417,"url":"https://lda.gov/api/v1/registrants/31417/","house_registrant_id":30989,"name":"PHILIPS HOLDING USA, INC.","description":"Manufacturing","address_1":"222 Jacobs Street","address_2":null,"address_3":null,"address_4":null,"city":"Cambridge","state":"MA","state_display":"Massachusetts","zip":"02141","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH SHARP","contact_telephone":"+1 202-940-5631","dt_updated":"2026-07-29T15:52:29.047153-04:00"},"client":{"id":138240,"url":"https://lda.gov/api/v1/clients/138240/","client_id":12,"name":"PHILIPS HOLDING USA INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-04-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2027 Veterans Affairs Appropriations, in general FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"S. 4784, FY27 National Defense Authorization Act (Sec. 804) and H.R. 8800, FY27 National Defense Authorization Act (Sec. 861, Sec. 862) Telehealth in DOD","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150641,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"PETER","last_name":"MERSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":14,"name":"Council of Economic Advisers (CEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1219, Oral Health Products Inclusion Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150641,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"PETER","last_name":"MERSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof S. 4519, the Medical Device Electronic Labeling Act (whole bill) and H.R. 1539, the Medical Device Electronic Labeling Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/f501e5d9-f740-4dd4-aba8-cd5812f6df09/","filing_uuid":"f501e5d9-f740-4dd4-aba8-cd5812f6df09","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/f501e5d9-f740-4dd4-aba8-cd5812f6df09/print/","filing_document_content_type":"text/html","income":null,"expenses":"470000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Elizabeth Sharp","dt_posted":"2026-10-19T16:26:25-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"222 Jacobs Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Cambridge","registrant_state":"MA","registrant_zip":"02141","registrant":{"id":31417,"url":"https://lda.gov/api/v1/registrants/31417/","house_registrant_id":30989,"name":"PHILIPS HOLDING USA, INC.","description":"Manufacturing","address_1":"222 Jacobs Street","address_2":null,"address_3":null,"address_4":null,"city":"Cambridge","state":"MA","state_display":"Massachusetts","zip":"02141","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH SHARP","contact_telephone":"+1 202-940-5631","dt_updated":"2026-07-29T15:52:29.047153-04:00"},"client":{"id":138240,"url":"https://lda.gov/api/v1/clients/138240/","client_id":12,"name":"PHILIPS HOLDING USA INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-04-02"},"lobbying_activities":[{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":14,"name":"Council of Economic Advisers (CEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1219, Oral Health Products Inclusion Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence S. 4519, the Medical Device Electronic Labeling Act (whole bill) and H.R. 1539, the Medical Device Electronic Labeling Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2027 Veterans Affairs Appropriations, in general FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"S. 4784, FY27 National Defense Authorization Act (Sec. 804) and H.R. 8800, FY27 National Defense Authorization Act (Sec. 861, Sec. 862) Telehealth in DOD","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}